crypto currency education- Top searches

By 2029, China will build about 10,000 superior specialties of traditional Chinese medicine. According to state administration of traditional chinese medicine, China will promote the construction of superior specialties of traditional Chinese medicine at different levels to further improve the clinical efficacy of traditional Chinese medicine. By 2029, the overall scale of superior specialties of traditional Chinese medicine will reach about 10,000. Recently, state administration of traditional chinese medicine issued opinions on accelerating the construction of superior specialties of traditional Chinese medicine, and put forward the requirements of strengthening the planning and layout of superior specialties of traditional Chinese medicine and promoting the construction of superior clusters of traditional Chinese medicine. (CCTV News)Qianjin Pharmaceutical Co., Ltd.: The subsidiary company obtained the dapoxetine hydrochloride Pharmaceutical Registration Certificate, and Qianjin Pharmaceutical announced that Qianjin Xiangjiang Pharmaceutical Co., Ltd. received the dapoxetine hydrochloride Pharmaceutical Registration Certificate approved and issued by National Medical Products Administration. The medicine is suitable for the treatment of male premature ejaculation patients aged 18 to 64.By 2029, China will build about 10,000 superior specialties of traditional Chinese medicine. According to state administration of traditional chinese medicine, China will promote the construction of superior specialties of traditional Chinese medicine at different levels to further improve the clinical efficacy of traditional Chinese medicine. By 2029, the overall scale of superior specialties of traditional Chinese medicine will reach about 10,000. Recently, state administration of traditional chinese medicine issued opinions on accelerating the construction of superior specialties of traditional Chinese medicine, and put forward the requirements of strengthening the planning and layout of superior specialties of traditional Chinese medicine and promoting the construction of superior clusters of traditional Chinese medicine. (CCTV News)

Schlegel, Governor of the Swiss National Bank: It aims to stabilize the inflation rate at 0-2%. We can tolerate inflation temporarily below the target range of 0-2%.Alleged of tax evasion, Adidas' German headquarters was raided for two days in a row. On December 11th, local time, criminal prosecutors and customs investigators raided Adidas' German headquarters for the second day in a row, which was an escalation of years of investigation on the sports brand's alleged tax evasion. The amount of tax evasion may exceed 1.1 billion euros. The European Prosecutor's Office (EPPO), headquartered in Luxembourg, said on the 11th that it was conducting a "criminal investigation" against a German sportswear trading enterprise group on the grounds that it was "suspected of tax evasion related to customs duties and import and sales taxes". Adidas said that this long-term investigation is unlikely to have "any significant financial impact".Mengke Pharmaceutical Co., Ltd.: The new packaging of Contizontamide tablets will be on the market soon. Mengke Pharmaceutical Co., Ltd. announced that the company has launched Contizontamide tablets with new packaging specifications, and a box of 12 tablets will be on the market soon. Contizontamide tablet is a new class 1 oxazolidinone antibacterial drug with global intellectual property rights. It was approved by National Medical Products Administration, China on June 1st, 2021 for the treatment of complex skin and soft tissue infections.

Dongpeng Beverage has set up two new companies in Hainan. According to the enterprise search APP, Hainan Dongpeng Beverage Marketing Co., Ltd. and Hainan Dongpeng Food & Beverage Co., Ltd. were established recently, and their legal representatives are both Liu Meili, with a registered capital of 100 million yuan. Enterprise investigation shows that both of them are wholly owned by Dongpeng Beverage.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)The OpenAI webpage shows that API, ChatGPT and Sora are all running normally.